Industry context
CrossingBridge PreMerger [SPC]
Pivot Data
Pivot Statistics
Next Pivot Prediction Last: $19.28
Little movement for CrossingBridge PreMerger.
CrossingBridge PreMerger (SPC) stock price ended the session unchanged on Thursday after the stock unchanged $0 (0.00%) from the previous session on extremely light volume. The stock held up slightly better than the falling NASDAQ (-0.40% down). With 0 shares traded, volume yesterday reached $0.00. This was 511 shares less than the prior day. Compared to the 10-day average of 840 shares, volume was less than the average.
CrossingBridge PreMerger signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-40%), medium- (-40%), and long-term (-40%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
CrossingBridge PreMerger Support & Resistance Levels
The stock is trading above the closest support level at $19.20. approximately $0.0700 (0.36%) away. This suggests it is currently acting as a floor, consolidating near support.The sup dis das support s119.2 -
CrossingBridge PreMerger Evaluation
- Short score: -3.47
- Medium score: -4.26
- Long score: -4.03
Relationship map
Correlation snapshot
Positioning pressure
Short interest pressure
Short positioning does not currently stand out as a dominant risk factor.
Updated 2026-01-15Income profile
Dividend profile
Yearly history
| Year | Dividend | Yield |
|---|---|---|
| - | $0 | 0.00% |
| - | $2.67 | 12.93% |
| - | $1.467 | 6.92% |
| - | $0.765 | 3.51% |
| - | $0 | 0.00% |
Recent payments
| Date | Dividend | Payment |
|---|---|---|
| 2025-12-24 | $2.67 | 2025-12-26 |
| 2024-12-26 | $1.123 | 2024-12-27 |
| 2024-09-24 | $0.344 | 2024-09-25 |
| 2023-12-26 | $0.765 | 2023-12-28 |
| 2022-12-29 | $0.215 | 2023-01-03 |
News flow
Latest company news
Market coverage
globenewswire.com Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial Jun 23, 2026 globenewswire.com Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio Feb 18, 2026 globenewswire.com Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 Dec 30, 2025 defenseworld.net SPC Financial Inc. Sells 970 Shares of NVIDIA Corporation $NVDA Nov 4, 2025Company releases
Company context
Company profile
The fund is an actively managed exchangetraded fund ETF that under normal market conditions will invest at least 80 of its net assets plus borrowings for investment purposes in shares of common stock and units of Special Purpose Acquisitions Companies SPACs that have yet to consummate a shareholderapproved merger or business combination The fund seeks to invest in publiclytraded SPACs that at the time of purchase are trading at or below the SPACs pro rata trust account value The fund is nondiversified
Navigation